-
EP4267558
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4267558
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2011137135
[XDI] (GLAXOSMITHKLINE LLC et al.) | Type: | Patent literature | Publication No.: | WO2018002827
[XDI] (GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD et al.) | Type: | Non-patent literature | Publication information: | [A] JOHN F. BAUER: "Polymorphism - A Critical Consideration in Pharmaceutical Development, Manufacturing, and Stability", JOURNAL OF VALIDATION TECHNOLOGY, 1 January 2008 (2008-01-01), France, pages 15 - 23, XP055517809, Retrieved from the Internet | Cited in | by applicant | Type: | Patent literature | Publication No.: | WO2011137135
| Type: | Patent literature | Publication No.: | WO2016020785
| Type: | Patent literature | Publication No.: | WO2018002827
| Type: | Non-patent literature | Publication information: | HEGADE, V.S. ET AL.: "Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study", LANCET, vol. 389, no. 10074, 2007, pages 1114 - 112 | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Sciences", MACK PUBLISHING COMPANY |